Its interesting because when we go back and look on the cover of our annual report from that year, theres a patient, Maria, and shes talking about her experience with Byetta, the brand name for exendin
DPP-4 Inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes
Wegovy Wegovy (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C: Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial
Hollowell JG, Staehling NW, Flanders WD, et al
People researching GLP-1 approaches during breastfeeding should apply the same caution to probiotic GLP-1 boosters as they would to pharmaceutical ones
